Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Chemours' (CC) Solid Product Offerings Make It A Must Buy

Published 10/02/2017, 09:30 PM

We believe that The Chemours Company (NYSE:CC) is a solid choice for investors seeking exposure in the chemical space. Its solid product offerings, strengthening end markets and expansionary efforts bode well for the future.

The stock has been upgraded to a Zacks Rank #1 (Strong Buy) on Oct 3.

Why the Upgrade?

Sentiments are positive for Chemours Company, as evident from 38.1% rally in its share price over the last six months. The stock has outperformed 12.9% gain recorded by the industry it belongs to over the same period.



Also, earnings estimates for the stock have been revised upward by a couple of analysts in the last 60 days. The Zacks Consensus Estimate for 2017 improved 6.8% from $3.40 to $3.63 while that for 2018 increased 22.5% from $4.08 to $5.

Chemours Company (The) Price and Consensus

Chemours Company (The) Price and Consensus | Chemours Company (The) Quote

We believe that strong demand for TiO2 in the coatings, plastic and papers end markets have boosted its growth prospects. Also, demand for fluorochemicals and fluoropolymers in the air conditioning, refrigeration, automotive, aerospace, consumer, wire & cable, electronics and telecommunications end markets have created solid long-term opportunities for Chemours Company.

Also, solid sodium cyanide is being increasingly used in gold production, oil refining, agriculture, industrial polymers and other industries. Market demand for solid sodium cyanide in Americas is projected to witnessed a 9% compound annual growth rate over the next five years. To tap the growing demand from the mining industry, the company started constructing a new Mining Solutions manufacturing facility in Mexico in June.

For 2017, Chemours Company anticipates gaining from the growing customer preference for its products, especially Ti-Pure titanium dioxide and Opteon refrigerants. Also, innovative products like Nafion 2050 and Teflon 30LX will attract customers. Adjusted earnings before interest, tax, depreciation and amortization are anticipated to be within $1.3-$1.4 billion range, up from the earlier forecast of $1.2-$1.3 billion.

Other Stocks to Consider

Chemours Company has a market capitalization of approximately $9.8 billion. Other stocks worth considering in the industry include FMC Corporation (NYSE:FMC) , Innophos Holdings, Inc. (NASDAQ:IPHS) and Air Products and Chemicals, Inc. (NYSE:APD) . While both FMC Corporation and Innophos Holdings sport a Zacks Rank #1, Air Products and Chemicals carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

FMC Corporation’s earnings estimates for 2018 improved in the last 60 days. Also, the company reported better-than-expected results in the last quarter, with a positive earnings surprise of 2.13%.

Innophos Holdings’ earnings estimates for 2017 improved in the last 60 days. Also, it pulled off an average positive earnings surprise of 13.07% for the last four quarters.

Air Products and Chemicals’ earnings estimates for fiscal 2018 were revised upward in the last 60 days. It delivered an average positive earnings surprise of 1.77% for the last four quarters.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Air Products and Chemicals, Inc. (APD): Free Stock Analysis Report

FMC Corporation (FMC): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Innophos Holdings, Inc. (IPHS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.